U S PHYSICAL THERAPY INC /NV Cash and Restricted Cash
U S PHYSICAL THERAPY INC /NV (USPH) had Cash and Restricted Cash of $24.89 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-07
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $24.89M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $28.44M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $35.57M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $31.10M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $24.89M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $28.44M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $35.57M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $31.10M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $34.09M 10-Q · filed 2026-08-07 |
| 2025-03-31 | $39.18M 10-Q · filed 2026-05-08 |
| 2024-12-31 | $41.36M 10-Q · filed 2026-08-07 |
| 2024-09-30 | $116.96M 10-Q · filed 2025-11-07 |
| 2024-06-30 | $112.91M 10-Q · filed 2025-08-08 |
| 2024-03-31 | $132.29M 10-Q · filed 2025-05-09 |
| 2023-12-31 | $152.82M 10-K · filed 2026-02-27 |
| 2023-09-30 | $147.69M 10-Q · filed 2024-11-08 |
| 2023-06-30 | $160.74M 10-Q · filed 2024-08-14 |
| 2023-03-31 | $32.60M 10-Q · filed 2024-05-08 |
| 2022-12-31 | $31.59M 10-K · filed 2026-02-27 |
| 2022-09-30 | $37.91M 10-Q · filed 2023-11-08 |
| 2022-06-30 | $48.57M 10-Q · filed 2023-08-09 |
| 2022-03-31 | $24.23M 10-Q · filed 2023-05-05 |
| 2021-12-31 | $28.57M 10-K · filed 2025-03-03 |
| 2021-09-30 | $19.19M 10-Q · filed 2022-11-08 |
| 2021-06-30 | $20.42M 10-Q · filed 2022-08-08 |
| 2021-03-31 | $17.94M 10-Q · filed 2022-05-09 |
| 2020-12-31 | $32.92M 10-K · filed 2024-02-29 |
| 2020-09-30 | $30.13M 10-Q · filed 2021-11-09 |
| 2020-06-30 | $43.55M 10-Q · filed 2021-08-09 |
| 2020-03-31 | $89.55M 10-Q · filed 2021-05-10 |
| 2019-12-31 | $23.55M 10-K · filed 2023-02-28 |
| 2019-09-30 | $27.86M 10-Q · filed 2020-11-06 |
| 2019-06-30 | $34.86M 10-Q · filed 2020-08-07 |
| 2019-03-31 | $20.24M 10-Q · filed 2020-05-21 |
| 2018-12-31 | $23.37M 10-K · filed 2022-03-01 |
| 2018-09-30 | $32.24M 10-Q · filed 2019-11-08 |
| 2018-06-30 | $27.15M 10-Q · filed 2019-08-09 |
| 2018-03-31 | $19.81M 10-Q · filed 2019-05-06 |
| 2017-12-31 | $21.93M 10-K · filed 2021-03-01 |
| 2016-12-31 | $20.05M 10-K · filed 2020-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |